In hepatocellular carcinoma, YTHDF2 silenced in human HCC cells or ablated in mouse hepatocytes provoked inflammation, vascular reconstruction, and metastatic progression (Hou et al., 2019). Here, YTHDF2 is linked to hepatocellular carcinoma.